Pfizer Seen Reporting Q2 Revenue In Line With Consensus, EPS Below Estimates, RBC Says
() -- Pfizer (PFE) is expected to report Q2 revenue in line with consensus estimates, while earnings per share are likely to come in about 3% below expectations due to an unfavorable gross margin mix and higher research and development spending to support pipeline programs, RBC Capital said in a Friday preview note. Th